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At last year's Convocation, my comments were entitled,
"What should a specialist be?" What special qualities of
the cardiologist lead to optimal care for the cardiac patient,
and what should be the role of the College in helping all of
us to fit into the research-learning-teaching continuum that
underlies excellent clinical care?
This morning, I would like to add to that view of the
role of the College, on the basis of my experiences during
the past year. My theme is really a call for the preservation
of subspecialty cardiovascular care through an expanded
role of the College in setting standards, serving as the profes-
sional and public representative for the highest possible
quality of care and helping to promote innovation in car-
diovascular care.
Cost containment and optimal medical care. Why do
we need to worry about the preservation of optimal car-
diovascular care? I think we all recognize the long-range
economic trends that have now begun to influence the prac-
tice of medicine. All indications are that in the future, med-
icine will be increasingly managed by the buyers of care
- including Medicare - and not by physicians. To quote
from a booklet prepared last year by John Hancock Mutual
Life Insurance Company:
Util ization management will be central to containing costs
as businesses become more willing to challenge physicians'
decisions regarding patient care. Business purchasers will
screen hospital admissions and examine efficiency more
closely than ever before through utilization reviews, The
cumulative impact of these interventions will have spillover
effects that will reverse long-held beliefs about how med-
icine should be practiced, Managed care is the wave of the
future . Consumers will increasingly be willing to accept
managed care systems which restrict their freedom at the
point of purchasing care. As they assume greater financial
responsibility and become more cost conscious, they will
value efficiency. And fewer people will have the "family
doctor" of yesteryear, due togreater mobility and physician
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specialization; thus they will appreciate the continuity of
care found in HMOs and the PPOs which use the primary
care physician to coordinate thepatient's care, Doctors will
lose influence. In the future , many physicians will face
heightened conflicts, experience less job satisfaction, and
earn lower incomes. By 1995 , more than halfof inpatient
care will be shifted to less costly settings.
The swing of the pendulum will be of considerable mag-
nitude as it accelerates from its present position. And, of
course, it is very likely to swing too far. Although there is
no question that medical care will and should be provided
in new ways, more efficiently and at lower cost than in the
past, inevitably we will see the quality of care deteriorate.
The Swedish experience . An interesting example has oc-
curred in Sweden, and I will refer to the recent experiences
of a young Swedish cardiologist, who spent some time with
us in San Diego in research training as a Fogarty Interna-
tional Fellow. He returned to Sweden to tell an interesting
story of problems, produced at least in part by a budget-
driven health care system.
According to Dr. Staffan Ahnve, at the present time it
is not easy for patients to obtain coronary angiography,
percutaneous transluminal coronary angioplasty or surgical
treatment in Sweden, and long delays lead those who can
afford it to leave the country for such procedures. He in-
dicates that in Sweden currently there are eight hospitals
capable of performing coronary angiography for a popula-
tion of 8.3 million compared, for example, with about 55
laboratories in Holland for a population of 14 million. These
procedures can be performed in one hospital in Stockholm,
which has a population of 1.8 million. The number of coro-
nary bypass operations and balloon angioplasty procedures
is estimated at 25D/million population in Sweden, compared
with 800/million in Holland and I,DOO/million in the United
States. It is Dr. Ahnve's view that high risk patients may
not survive as long as they would have if such treatments
were more readily available.
All of this suggests the possibility that access to some
types of advancedcardiovascular care in Sweden is less than
it should be and it certainly appears to be less than in some
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other countries. Because actual figures are not available,
one can only guess that such policies have led to less than
optimal care for some segments of the population. My pur-
pose in alluding to the Swedish experiences is neither to
draw invidious comparisons nor to intimate that there are
not many fine physicians in Sweden who deliver optimal
medical care. Rather, it is to indicate those scenarios toward
which "cost containment" considerations alone might lead
us, with the potential end point of less than optimal health
care.
Expanding College roles. Now, in proposing some ex-
panded roles for the College, I am not suggesting less em-
phasis on the traditional important functions of the College
in continuing education, as consultant to the Federal Gov-
ernment and other health care organizations and as a poli-
cymaker for our specialty. Our Government Relations Com-
mittee under Dr. Anthony DeMaria is widening its activities,
monitoring events in Washington and actively communi-
cating with congressional leaders. In the area of policy-
making, I would cite in particular the valuable function of
our Bethesda Conferences in providing consensus policy
statements on matters of significance. Such a conference
concerned with manpower issues will convene later this
year, and I am sure by now most of you know that the
recommendation of the Bethesda Conference on Training
advocating 3 years of specialty fellowship in cardiology,
which was supported by our Board of Trustees, has now
been adopted by the Board of Governors of the American
Board of Internal Medicine, for implementation several years
from now.
What should be this new or expanded agenda for the
College as we face changing notions of medical specialty
care in the United States?
Setting standards. First, I believe that we must be in-
creasingly involved in setting standards, and by this I am
not referring to cookbook approaches to ordinary cardiac
care. Certainly, we now contribute to standards. For ex-
ample, the publications of the ACCIAHA Task Force on
Cardiovascular Procedures have been extremely valuable,
with guidelines pending on such topics as coronary angi-
ography, percutaneous transluminal coronary angioplasty,
ambulatory electrocardiographic monitoring and electro-
physiologic testing. Also, the Long-Range Planning Com-
mittee currently is examining ways to improve and accel-
erate our technology assessment capabilities. It is hoped that
both of these activities will increase. Beyond this, however,
should we not be continuously defining and redefining op-
timal current care for selected disease settings, such as the
early care of acute myocardial infarction, unstable angina
pectoris or the treatment of valvular heart disease? In this
role, we are advocates for both the patient and our profession
in that we, who are best equipped to decide, are stating
when special care is needed and what type is appropriate.
It seems highly likely that if we do not perform this function,
it will be done for us by those considerably less knowl-
edgeable and with perhaps less noble agendas!
Last year, at the Pfizer President's Forum, in Washing-
ton, one of the speakers was Congressman Claude Pepper
of Florida, who has a rather lengthy historical perspective
on health care in this country. He said the following:
I'm 85 years old. I guess I must accept the fact that I'm
not going to live forever, although I'm still rather hopeful
about it. But I wantedjust to offer a word or two from the
heart.
You are the leaders of the medical profession in this
country. You're the best qualified people to providea med-
icalcare systemthat will meet the needsof all of the people.
Youhavea responsibility, I think, notonly to rendermedical
serviceto patients andclients, youalso havea responsibility
to our American society to help them, to lead them, to guide
them in trying to set up the best medical system that Amer-
ican ingenuity and dedication can provide.
Congressman Pepper has been actively involved in and
concerned about standards and access to care for the elderly,
a concern that we all share, and we must also include in
this concern access to quality care for the poor and the
chronically ill, because many prepaid plans cater to those
who are, for the most part, working and well.
Increased communication to noncardiovascular special-
ists. Second, I believe that we must enhance our activities
as informed educators, or informed persuaders, if you will,
about the value of what the cardiovascular specialist can do.
This has been an area of interest to our Strategic Planning
Committee under Dr. Robert Frye, as well as to a Working
Group of the Executive Committee chaired by Dr. Jack
Davis. The issue of how to demonstrate improved clinical
outcome due to optimal specialty cardiovascular care is, at
best, a complex one. Nevertheless, our future depends on
developing ways to communicate just what it is that high
quality cardiovascular care can accomplish, both in disease
treatment and prevention, and this information must be com-
municated to the nonspecialty physician, to the Congress,
to other government and state agencies, to private health
care providers and to the public. Certainly, the public is
increasingly informed from a variety of sources. They ap-
pear to crave up to date health care information, as evi-
denced by the popularity of the Specialty Update in Car-
diology on Lifetime cable TV, hosted by Dr. Jeremy Swan,
even though the program is actually aimed at physicians. It
seems to me that a program of general education on what
constitutes optimal cardiovascular health care, sponsored by
the College, would benefit the government, the public and
the profession.
There is a third area in which I believe the College should
consider expanding its contributions, and that is at the re-
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search end of the continuum. Certainly the College is now
contributing enormously to maintaining and teaching the
scientific basis of medical practice through the Journal of
the American College of Cardiology. our Annual Meeting,
our continuing education programs at Heart House and
throughout the country, through ACCEL and our interna-
tional education program.
New efforts in research and research training . It has
been said that cardiology must become based on research
in molecular biology, along with many of the other sub-
specialties of internalmedicine, and indeed, this is just now
slowly beginning to occur. However, research must always
operate simultaneously at the molecular, cellular, organic
and patient levels, and innovations in the quality of health
care can emerge from any of those levels. For example,
Brown and Goldstein started with very basic studies on the
low density lipoprotein receptor, which required the use of
cultured cells from patients with familial hypercholestero-
lemia, and now they are thinking in terms of low density
lipoprotein receptor down-regulation, instead of congenital
receptor absence, as a potential mechanism for lipid dis-
orders in the general population. On the other hand, a re-
verse pathway beginning with clinical and applied labora-
tory research has linked early clinical work on intravenous
thrombolysis beginning in the 1950s with Chazov's initial
direct demonstration of the possibility of coronary throm-
bolysis, Braunwald's concept that infarct size might be re-
duced, our experimental studies in San Diego showing de-
creased tissue damage and recovery of regional contractile
function after direct coronary artery reperfusion, and finally
with the demonstration by Dewood of a high prevalenceof
thrombosis in acute myocardial infarctionand definitive an-
giographic studies by Rentrop and others showing effective
intracoronary thrombolysis. All of this has, in turn, produced
an efflorescence of basic research on blood clotting, on the
blood vessel wall, on the molecular basis of thrombolysis
and on the production by the techniques of molecular bi-
ology of new agents to accomplish thrombolysis.
The College should, of course, continue its strong sup-
port for the programs of the National Heart, Lung, and
Blood Institute, as well as the American Heart Association,
in their direct supportof research. We should be an advocate
forall kindsof research, includingbasic, appliedandclinical
investigation. But perhaps we could do more to promote
clinical investigation. We are already in a partnership with
Merck to support research training of young investigators
in the United States. For example, the College might, per-
haps with industry, consider supporting in the future a two-
way international exchange of young clinical investigators
for periods of clinical research and training.
In any case, if we are to set standards for care, we should
also support vigorously the research and research training
that can lead to continuous upgrading of those standards.
In summary. then, I envision a broadening role for the
College in the future, encompassing more involvement with
standards for cardiovascularcare, new avenuesof education
on what our specialty can provide, aimed at nonspecialty
audiences, and enhanced efforts by the College to promote
research and training. Certainly, several of these many top-
ics may emerge from the strategic planning process now
underway under Dr. Robert Frye, and I am hopeful that
they will appear as new items on the working agenda of
our College.
Acknowledging the brilliant advances in cardiovascular
research, clinical cardiology and cardiac surgery during the
past 50 years, we must admit that there are also many other
problems and opportunities that confront medicine in gen-
eral. These include the need for more emphasis on preven-
tion, for better ways to treat an aging population and for
ways to maintain a proper balance between technical med-
icineand theGreek ideaof the physicianas patient-colleague
and our need to consider the ethical dimensions of medical
practice in this complex, fiscally oriented culture, a topic
that will be addressed by Dr. Edmund Pelligrino in his
Convocation address.
In closing, I trust that each of you will become increas-
ingly involved in the activitiesof the College, which should
becomeeasier as CollegeChapters develop in variousstates.
There are interesting and challenging times ahead and we
need not consider my quotation from an insurancecompany
as a sentence of doom. Rather, we should consider it a
signal of impending change, which we can help to shape.
